Toward 70% cervical cancer screening coverage: Technical challenges and opportunities to increase access to human papillomavirus (HPV) testing
- PMID: 37585432
- PMCID: PMC10431663
- DOI: 10.1371/journal.pgph.0001982
Toward 70% cervical cancer screening coverage: Technical challenges and opportunities to increase access to human papillomavirus (HPV) testing
Abstract
The World Health Organization (WHO) has called for the elimination of cervical cancer as a public health problem. Cervical cancer screening through human papillomavirus (HPV) testing is a core component of the strategy for elimination, with a set target of screening 70% of women twice in their lifetimes. In this review, we discuss technical barriers and opportunities to increase HPV screening globally.
Copyright: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Conflict of interest statement
The authors have read the journal’s policy and have the following competing interests: PC and KK are employees of the National Cancer Institute (NCI). BV is an employee of FIND (https://finddx.org). PC has received HPV tests and assays for research at a reduced or no cost from Roche, Becton Dickinson, Cepheid, Atila Biosystems, and Arbor Vita Corporation outside of the submitted work. This does not alter adherence to PLOS ONE policies on sharing data and materials. There are no patents, products in development or marketed products associated with this research to declare.
Figures
References
-
- World Health Organization. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention: Second edition. 2021. - PubMed
-
- World Health Organization. Cervical Cancer Country Profiles. 2021.
-
- Bruni L, Serrano B, Roura E, Alemany L, Cowan M, Herrero R, et al.. Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis. Lancet Glob Health. 2022;10: e1115–e1127. doi: 10.1016/S2214-109X(22)00241-8 - DOI - PMC - PubMed
-
- Castle PE. When Less is More. JNCI: Journal of the National Cancer Institute. 2017;109: 240. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources